Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31true2022-08-08falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.No description of principal activity4false 14283373 2022-08-07 14283373 2022-08-08 2023-12-31 14283373 2021-08-08 2022-08-07 14283373 2023-12-31 14283373 c:Director2 2022-08-08 2023-12-31 14283373 d:CurrentFinancialInstruments 2023-12-31 14283373 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 14283373 d:ShareCapital 2023-12-31 14283373 d:RetainedEarningsAccumulatedLosses 2023-12-31 14283373 c:OrdinaryShareClass1 2022-08-08 2023-12-31 14283373 c:OrdinaryShareClass1 2023-12-31 14283373 c:OrdinaryShareClass2 2022-08-08 2023-12-31 14283373 c:OrdinaryShareClass2 2023-12-31 14283373 c:FRS102 2022-08-08 2023-12-31 14283373 c:AuditExempt-NoAccountantsReport 2022-08-08 2023-12-31 14283373 c:FullAccounts 2022-08-08 2023-12-31 14283373 c:PrivateLimitedCompanyLtd 2022-08-08 2023-12-31 14283373 e:PoundSterling 2022-08-08 2023-12-31 14283373 d:EntityControlledByKeyManagementPersonnel1 2022-08-08 2023-12-31 14283373 d:EntityControlledByKeyManagementPersonnel1 2023-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14283373









SINA MEDICAL GLASS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 DECEMBER 2023

 
SINA MEDICAL GLASS LIMITED
REGISTERED NUMBER: 14283373

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023


2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
11,557

Cash at bank and in hand
 5 
86,163

Creditors: amounts falling due within one year
 6 
(123,262)

Net current liabilities
  
 
 
(25,542)

  

Net liabilities
  
(25,542)


Capital and reserves
  

Called up share capital 
 7 
100

Profit and loss account
  
(25,642)

  
(25,542)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the Statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 August 2024.




B Farsian
Director

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
SINA MEDICAL GLASS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

Sina Medical Glass Limited is a company limited by shares incorporated in England and Wales. The address of the registered office is 87 Abingdon Road, London, United Kingdom, W8 6AW.
The company was incorporated on 8 August 2022 and commenced trading on 12 June 2023.
The company specialises in manufacturing and processing of glassware.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

The financial statements have been prepared on a going concern basis notwithstanding the net liabilities of £25,542. The directors and shareholders have provided an undertaking that they will continue to support the company for the foreseeable future to enable the company's liabilities to be met as they fall due and specifically for a period of not less than twelve months from the date of signing these financial statements. On this basis, the directors believes that the preparation of the accounts on a going concern basis is appropriate.

 
2.3

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the period was 4.


Page 2

 
SINA MEDICAL GLASS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

4.


Debtors

2023
£


Other debtors
4,890

Prepayments and accrued income
6,667

11,557



5.


Cash and cash equivalents

2023
£

Cash at bank and in hand
86,163

86,163



6.


Creditors: Amounts falling due within one year

2023
£

Trade creditors
2,321

Amounts owed to shareholders
100,000

Other creditors
13,693

Accruals and deferred income
7,248

123,262


Page 3

 
SINA MEDICAL GLASS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

7.


Share capital

2023
£
Allotted, called up and fully paid


80 Ordinary A shares of £1 each
80
20 Ordinary B shares of £1 each
20

100


On incorporation, the company issued 100 Ordinary shares of £1 each for cash consideration, at par value.
On 8 November 2022, 100 Ordinary shares of £1 each were re-designated as 80 Ordinary A shares of £1 each and 20 Ordinary B shares of £1 each.
The Ordinary A and Ordinary B £1 shares rank pari passu except in voting rights, where each Ordinary A share conveys one vote, but each Ordinary B share has four votes.


8.


Related party transactions

Included within amounts owed to shareholders within one year is £65,000 owed to SGC Group INTL Limited which is a shareholder of the company.
 
Included within amounts owed to shareholders is £35,000 owed to Hambleden Capital Partners LLP which is a shareholder of the company.
 
Included within other creditors due within one year is an amount of £13,693 due from a company with a common director.


9.


Controlling party

There is no controlling party.

 
Page 4